It also helps reduce appetite by interacting with certain parts of the brain that process hunger and satiety
In patients with type 2 diabetes at high cardiovascular risk, semaglutide demonstrated significantly lower rates of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke compared to placebo, establishing the noninferiority of semaglutide
Emergency Procedures : Learn emergency procedures for spills, leaks, fires, or exposure incidents
Victoza is FDA-approved for two indications: To improve blood sugar control in adults and children aged 10 and older with type 2 diabetes To reduce cardiovascular risk in adults with type 2 diabetes and heart disease Saxenda is FDA-approved for weight loss in the following populations: Adults with obesity (body mass index, or BMI, of 30 or higher) Adults with overweight (BMI of 27 or higher) and a weight-related health condition, such as high blood pressure or cholesterol Children aged 12 and older with obesity The FDA approved a generic version of Victoza , known simply as liraglutide , in late 2024
Each meal should contain 200 to 400 calories rather than 600 to 800